We should set up a pool . . .
Your guess is as good as mine, and I'll defer to J. Saf, B. Greene, Rob, Wendell and others who know more on the subject . . . but here's my entry:
$.08/share earnings pre-market Tuesday. If there's any news this week, it is most likely to be Sylvan. (INS not ready; Conavi probably not ready, Oracle -- I wish!, nothing else really close). With good earnings, stock peaks at $13+, settles above $12 by Friday. With a good Sylvan announcement as well, stock peaks close to $15, settles above $13 by Friday. Very outside chance of a modest short squeeze. If stock is within predictions (say .03 to .05) but otherwise looks good, peaks about $12, settles about $11.50 -- and say goodbye to single digits forever.
The reason why this stock is not likely to get to $30 in time for Cabo, I believe (with apologies to Brad), is that there is still a market risk to be overcome; there has to be proof that, despite Ratman, this technology is actually being sold commercially and not just planned for. INS or other government orders will not satisfy this concern. The good news here is that there is still time for people to load up on this stock over the next six months, although at something higher than its present price. When I look at this market, I see IDX smart and prospering, and its competition being driven out of business. That gives me a lot of confidence.
What say the rest of you? |
